These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23007408)

  • 1. Decreased levels of nitric oxide production and nitric oxide synthase-2 expression are associated with the development and metastasis of hepatocellular carcinoma.
    Zhou L; Wang Y; Tian DA; Yang J; Yang YZ
    Mol Med Rep; 2012 Dec; 6(6):1261-6. PubMed ID: 23007408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of nitric oxide synthase in human gastric carcinoma and its relation to p53, PCNA.
    Wang YZ; Cao YQ; Wu JN; Chen M; Cha XY
    World J Gastroenterol; 2005 Jan; 11(1):46-50. PubMed ID: 15609395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma.
    Ikeguchi M; Ueta T; Yamane Y; Hirooka Y; Kaibara N
    Clin Cancer Res; 2002 Oct; 8(10):3131-6. PubMed ID: 12374680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress-induced 1, N6-ethenodeoxyadenosine adduct formation contributes to hepatocarcinogenesis.
    Zhou L; Yang Y; Tian D; Wang Y
    Oncol Rep; 2013 Mar; 29(3):875-84. PubMed ID: 23292006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and clinical significance of TAp73alpha, p53, PCNA and apoptosis in hepatocellular carcinoma.
    Qin HX; Nan KJ; Yang G; Jing Z; Ruan ZP; Li CL; Xu R; Guo H; Sui CG; Wei YC
    World J Gastroenterol; 2005 May; 11(18):2709-13. PubMed ID: 15884108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expressions of inducible nitric oxide synthase and vascular endothelial growth factor and their relationship with microvessel density in hepatocellular carcinoma].
    Xiao G; Zhang WM; Zhang M; Xie D; Guo AL; Wen JM
    Ai Zheng; 2005 Jan; 24(1):99-103. PubMed ID: 15642211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of centromere protein A in hepatocellular carcinoma].
    Li YM; Liu XH; Cao XZ; Wang L; Zhu MH
    Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):175-8. PubMed ID: 17535684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide inhibits autophagy and promotes apoptosis in hepatocellular carcinoma.
    Zhang X; Jin L; Tian Z; Wang J; Yang Y; Liu J; Chen Y; Hu C; Chen T; Zhao Y; He Y
    Cancer Sci; 2019 Mar; 110(3):1054-1063. PubMed ID: 30657629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
    Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
    Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PCNA-associated factor (KIAA0101/PCLAF) overexpression and gene copy number alterations in hepatocellular carcinoma tissues.
    Tantiwetrueangdet A; Panvichian R; Sornmayura P; Leelaudomlipi S; Macoska JA
    BMC Cancer; 2021 Mar; 21(1):295. PubMed ID: 33743635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of p42.3 promotes cell growth and tumorigenicity in hepatocellular carcinoma.
    Sun W; Dong WW; Mao LL; Li WM; Cui JT; Xing R; Lu YY
    World J Gastroenterol; 2013 May; 19(19):2913-20. PubMed ID: 23704824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NKD1 correlates with a poor prognosis and inhibits cell proliferation by inducing p53 expression in hepatocellular carcinoma.
    Zhang S; Li J; Wang X
    Tumour Biol; 2016 Oct; 37(10):14059-14067. PubMed ID: 27507614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of human telomerase reverse transcriptase gene in HCC does not depend on proliferating cell nuclear antigen and P53].
    Zhang D; Li KZ; Dou KF; Gao ZQ; Song ZS; Zhao QC; Fu YC
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Nov; 20(6):721-2. PubMed ID: 15555445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIRT7 regulates hepatocellular carcinoma response to therapy by altering the p53-dependent cell death pathway.
    Zhao J; Wozniak A; Adams A; Cox J; Vittal A; Voss J; Bridges B; Weinman SA; Li Z
    J Exp Clin Cancer Res; 2019 Jun; 38(1):252. PubMed ID: 31196136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway.
    Zhu H; Wang J; Yin J; Lu B; Yang Q; Wan Y; Jia C
    Cell Physiol Biochem; 2018; 45(3):1121-1135. PubMed ID: 29439259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the G1-S modulators in hepatitis B virus-related hepatocellular carcinoma and dysplastic nodule: association of cyclin D1 and p53 proteins with the progression of hepatocellular carcinoma.
    Choi YL; Park SH; Jang JJ; Park CK
    J Korean Med Sci; 2001 Aug; 16(4):424-32. PubMed ID: 11511787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell proliferation, apoptosis and the related regulators p27, p53 expression in hepatocellular carcinoma.
    Jing Z; Nan KJ; Hu ML
    World J Gastroenterol; 2005 Apr; 11(13):1910-6. PubMed ID: 15800979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
    Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
    Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
    Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC
    Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma.
    Lin SY; Pan HW; Liu SH; Jeng YM; Hu FC; Peng SY; Lai PL; Hsu HC
    Clin Cancer Res; 2008 Aug; 14(15):4814-20. PubMed ID: 18676753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.